Results 21 to 30 of about 5,065,448 (337)

Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors

Scientific Reports, 2022
Since late 2019, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant spread of COVID-19 have given rise to a worldwide health crisis that is posing great challenges to public health and clinical treatment, in ...
Haimei Li, Bo Zhu, Baowei Li, Limei Chen, Xuerao Ning, Hang Dong, Jingru Liang, Xueying Yang, Jinhua Dong, Hiroshi Ueda   +9 more
doaj   +1 more source

Antibody and B cell responses to Plasmodium sporozoites [PDF]

, 2014
Antibodies are capable of blocking infection of the liver by Plasmodium sporozoites. Accordingly the induction of anti-sporozoite antibodies is a major aim of various vaccine approaches to malaria.
Cockburn, Ian A., Dups, Johanna N., Pepper, Marion   +2 more
core   +2 more sources

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Science, 2020
An antibody defense against COVID-19 One of the responses of the immune system to invading viruses is the production of antibodies. Some of these are neutralizing, meaning that they prevent the virus from being infectious, and can thus be used to treat ...
Yan Wu, Feiran Wang, Chenguang Shen, Weiyu Peng, Delin Li, Cheng Zhao, Z. Li, Shihua Li, Y. Bi, Yang Yang, Y. Gong, Haixia Xiao, Z. Fan, Shuguang Tan, Guizhen Wu, W. Tan, Xuancheng Lu, Changfa Fan, Qihui Wang, Yingxia Liu, Chen Zhang, J. Qi, G. Gao, F. Gao, Lei Liu   +24 more
semanticscholar   +1 more source

Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

Frontiers in Immunology, 2016
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld, Frank Grosveld   +7 more
doaj   +1 more source

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

Frontiers in Oncology, 2022
DNA-encoded delivery and in vivo expression of antibody therapeutics presents an innovative alternative to conventional protein production and administration, including for cancer treatment.
Kevin Hollevoet, Kevin Hollevoet, Debby Thomas, Debby Thomas, Griet Compernolle, Griet Compernolle, Giles Vermeire, Elien De Smidt, Elien De Smidt, Stéphanie De Vleeschauwer, Trevor R. F. Smith, Paul D. Fisher, Maarten Dewilde, Maarten Dewilde, Nick Geukens, Paul Declerck, Paul Declerck   +16 more
doaj   +1 more source

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Science, 2020
SARS-CoV-2 antibodies persist As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al.
A. Wajnberg, F. Amanat, A. Firpo, D. Altman, M. Bailey, M. Mansour, Meagan McMahon, Philip Meade, D. R. Mendu, K. Muellers, D. Stadlbauer, K. Stone, Shirin Strohmeier, V. Simon, J. Aberg, D. Reich, F. Krammer, C. Cordon-Cardo   +17 more
semanticscholar   +1 more source

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Science, 2021
Description Community of antibodies against COVID-19 The severe acute respiratory syndrome coronavirus 2 spike protein is the basis of many vaccines and is a primary target of neutralizing antibodies after COVID-19 infection.
K. Hastie, Haoyang Li, Daniel H Bedinger, S. Schendel, S. Dennison, Kan Li, V. Rayaprolu, Xiaoying Yu, Colin J. Mann, M. Zandonatti, Ruben Diaz Avalos, D. Żyła, Tierra Buck, S. Hui, K. Shaffer, C. Hariharan, J. Yin, Eduardo Olmedillas, Adrian Enriquez, D. Parekh, Milite Abraha, Elizabeth Feeney, Gillian Q. Horn, Y. Aldon, Hanif Ali, Sanja Aracic, Ronald R Cobb, Ross S. Federman, Joseph M. Fernandez, J. Glanville, Robin Green, G. Grigoryan, Ana G. Lujan Hernandez, D. Ho, Kuan-Ying A. Huang, J. Ingraham, Weidong Jiang, P. Kellam, Cheolmin Kim, Minsoo Kim, Hyeong Mi Kim, Chao Kong, S. Krebs, F. Lan, Guojun Lang, Sooyoung Lee, Cheuk Lun Leung, Junli Liu, Yanan Lu, Anna J. MacCamy, A. McGuire, A. Palser, T. Rabbitts, Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi, R. Sanders, A. Sato, L. Schweizer, Jimin Seo, Bingqing Shen, Jonne L. Snitselaar, L. Stamatatos, Yongcong Tan, M. Tomic, M. V. van Gils, S. Youssef, Jian Yu, Tom Z. Yuan, Qian Zhang, B. Peters, G. Tomaras, T. Germann, E. Saphire   +72 more
semanticscholar   +1 more source

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling, Luxia Zheng, Mingming Xu, Gang Chen, Xiao Wang, Danzhuo Mao, Hong Shao   +6 more
doaj   +1 more source

Characterization of monoclonal and polyclonal antibodies to bovine enteric coronavirus: Establishment of an efficient ELISA for antigen detection in feces [PDF]

, 1989
Monoclonal antibodies to bovine enteric coronavirus (BEC) were produced. Additionally, polyclonal antibodies were made in rabbits and guinea pigs and extracted from the yolk of immunized hens.
Czerny, C. P., Eichhorn, Werner
core   +1 more source

Acknowledgement to Reviewers of Antibodies in 2014

Antibodies, 2015
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Antibodies Editorial Office
doaj   +1 more source